Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
Lee
P H
PH
Department of Surgery, College of Medicine, National Taiwan University, Taipei, Taiwan. pohuang@ha.mc.ntu.edu.tw
Hu
R H
RH
Tsai
M K
MK
Ho
M C
MC
Lai
H S
HS
Lai
M Y
MY
Yang
P M
PM
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000188:drug therapy* / Q000601:surgery*; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D019259:Lamivudine; D016572:Cyclosporine; C045213:hepatitis B hyperimmune globulin